Public Profile

C.H. Boehringer Sohn AG & Co. KG

C.H. Boehringer Sohn AG & Co. KG, commonly referred to as Boehringer, is a prominent player in the pharmaceutical and animal health industries, headquartered in Germany. Founded in 1885, the company has established itself as a leader in research-driven healthcare solutions, focusing on innovative products for both human and veterinary medicine. With a strong presence in Europe, North America, and Asia, Boehringer is renowned for its commitment to advancing health through science. The company offers a diverse range of core products, including prescription medications and vaccines, distinguished by their quality and efficacy. Boehringer's dedication to research and development has led to significant milestones, solidifying its market position as a trusted name in the industry.

DitchCarbon Score

How does C.H. Boehringer Sohn AG & Co. KG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

20

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

C.H. Boehringer Sohn AG & Co. KG's score of 20 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Let us know if this data was useful to you

C.H. Boehringer Sohn AG & Co. KG's reported carbon emissions

C.H. Boehringer Sohn AG & Co. KG, headquartered in Germany, currently does not have publicly available carbon emissions data or specific reduction targets. As a result, there are no reported figures for their Scope 1, 2, or 3 emissions. The company has not outlined any formal climate commitments or initiatives aimed at reducing carbon emissions. In the absence of specific data, it is unclear how they are addressing climate change or contributing to sustainability efforts within the industry.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. C.H. Boehringer Sohn AG & Co. KG's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for C.H. Boehringer Sohn AG & Co. KG is in DE, which has a medium grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

C.H. Boehringer Sohn AG & Co. KG is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Lonza

CH
Furniture; other manufactured goods n.e.c. (36)
Updated 2 days ago

Wuxi Biologics

CN
Medical, precision and optical instruments, watches and clocks (33)
Updated 2 days ago

Recipharm

SE
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Adm

US
Food products nec
Updated 1 day ago

Astra Zeneca

GB
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Amgen

US
Chemicals nec
Updated 2 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers